These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 2175539)
21. Platelet 3H-imipramine binding sites in depressed patients and healthy controls: a comparison between morning and afternoon samples. Gentsch C; Lichsteiner M; Gastpar M; Gastpar G; Feer H J Affect Disord; 1989; 16(1):65-70. PubMed ID: 2536764 [TBL] [Abstract][Full Text] [Related]
23. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects. Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077 [TBL] [Abstract][Full Text] [Related]
24. Differential 3H-imipramine platelet binding in patients with panic disorder and depression. Innis RB; Charney DS; Heninger GR Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580 [TBL] [Abstract][Full Text] [Related]
26. Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression. DeMet EM; Bell KM; Reist C; Gerner RH; Chicz-DeMet A Psychiatry Res; 1990 Dec; 34(3):315-29. PubMed ID: 1963694 [TBL] [Abstract][Full Text] [Related]
27. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients. Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616 [TBL] [Abstract][Full Text] [Related]
28. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients. Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192 [TBL] [Abstract][Full Text] [Related]
29. Platelet 3H-paroxetine binding in depressed patients. D'haenen H; De Waele M; Leysen JE Psychiatry Res; 1988 Oct; 26(1):11-7. PubMed ID: 2976947 [TBL] [Abstract][Full Text] [Related]
36. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine. Lawrence KM; Falkowski J; Jacobson RR; Horton RW Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891 [TBL] [Abstract][Full Text] [Related]
37. A longitudinal study of intact platelet 3H-imipramine binding in 12 normal human subjects. Goziotis A; Tang SW Psychiatry Res; 1988 Nov; 26(2):157-62. PubMed ID: 2853400 [TBL] [Abstract][Full Text] [Related]
38. Studies on the serotonin transporter in platelets. Langer SZ; Galzin AM Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377 [TBL] [Abstract][Full Text] [Related]
39. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study. Bech P; Eplov L; Gastpar M; Gentsch C; Mendlewicz J; Plenge P; Rielaert C; Mellerup ET Pharmacopsychiatry; 1988 May; 21(3):147-50. PubMed ID: 2841696 [No Abstract] [Full Text] [Related]